Package Leaflet: Information for the User
Viaflo Glucose 3.3% and Sodium Chloride 0.3%, Solution for Infusion
Active substance: sodium chloride, glucose
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information:
Viaflo Glucose 3.3% and Sodium Chloride 0.3% is a solution of the following substances in water:
Glucose is one of the body's sources of energy. This solution provides 132 kilocalories per liter. Sodium and chloride are chemical substances found in the blood.
Viaflo Glucose 3.3% and Sodium Chloride 0.3% is used:
Viaflo Glucose 3.3% and Sodium Chloride 0.3% should not be given to you if you have any of the following conditions
Warnings and precautions
Tell your doctor if you have or have had any of the following conditions:
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you are being given this solution, your doctor will take blood and urine samples to check:
Since Viaflo Glucose 3.3% and Sodium Chloride 0.3% contains sugar (glucose), it may increase your blood sugar levels (hyperglycemia). If this happens, your doctor may:
This is particularly important:
Your doctor should consider whether you are receiving parenteral nutrition (nutrition given through a vein). During prolonged treatment with Viaflo Glucose 3.3% and Sodium Chloride 0.3%, you may need to receive additional nutrition. Your doctor should check your blood potassium levels to prevent them from dropping too low (hypokalemia).
Children
Special care should be taken when giving this solution to children, babies, and newborns (especially premature babies and those with low birth weight). Children, babies, and newborns may not have a good ability to handle the chemicals in the solution.
Younger children are at higher risk of developing low or high blood sugar levels and therefore need careful monitoring during treatment to ensure proper control of blood sugar levels. Low blood sugar levels in newborns can cause prolonged seizures, coma, and brain damage. High blood sugar levels have been associated with brain hemorrhages, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections, lung problems, prolonged hospital stay, and death.
Children are at higher risk of developing low sodium levels in the blood (hyponatremia). Hyponatremia can cause headache, nausea, seizures, lethargy, coma, brain inflammation (cerebral edema), and death. Acute hyponatremic encephalopathy is a serious complication, especially in children.
Your doctor is aware of all of the above and will carefully monitor the levels of chemicals such as glucose (sugar), sodium, and chloride in your child's blood (plasma electrolytes).
Other medicines and Viaflo Glucose 3.3% and Sodium Chloride 0.3%
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
It is particularly important that you tell your doctor if you are taking:
These medicines can cause the body to retain sodium and water, leading to tissue swelling due to fluid accumulation under the skin (edema) or high blood pressure (hypertension).
Some medicines affect the hormone vasopressin. These may include:
Other medicines that may be affected by or affect Viaflo Glucose 3.3% and Sodium Chloride 0.3% are:
Using Viaflo Glucose 3.3% and Sodium Chloride 0.3% with food and drink
Ask your doctor about what you can eat or drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or nurse for advice before using this medicine.
Viaflo Glucose 3.3% and Sodium Chloride 0.3% can be used safely during pregnancy and breastfeeding.
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Viaflo Glucose 3.3% and Sodium Chloride 0.3% does not affect your ability to drive or use machines.
Viaflo Glucose 3.3% and Sodium Chloride 0.3% will be given to you by a doctor or nurse. Your doctor will decide how much you need and when it should be given. This will depend on your age, weight, physical condition, and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
DO NOT receive Viaflo Glucose 3.3% and Sodium Chloride 0.3% if there are particles floating in the solution or if the packaging is damaged in any way.
Viaflo Glucose 3.3% and Sodium Chloride 0.3% is usually given through a plastic tube attached to a needle inserted into a vein. A vein in the arm is usually used to give the infusion. However, your doctor may give you the medicine in another way.
Before and during the infusion, your doctor will check:
Any unused solution should be discarded. DO NOT receive Viaflo Glucose 3.3% and Sodium Chloride 0.3% from a started bag.
If you receive more Viaflo Glucose 3.3% and Sodium Chloride 0.3% than you should
If you receive too much Viaflo Glucose 3.3% and Sodium Chloride 0.3% solution or if it is given too quickly, you may experience the following symptoms:
If you develop these symptoms, tell your doctor immediately. The infusion will be stopped and you will receive treatment based on your symptoms.
If a medicine has been added to the Viaflo Glucose 3.3% and Sodium Chloride 0.3% solution before administration, this medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
If you stop receiving Viaflo Glucose 3.3% and Sodium Chloride 0.3% infusion
Your doctor will decide when you should stop receiving this infusion.
If you have any further questions about the use of this medicine, ask your doctor or nurse.
Like all medicines, Viaflo Glucose 3.3% and Sodium Chloride 0.3% can cause side effects, although not everybody gets them.
Side effects may be related to Viaflo Glucose 3.3% and Sodium Chloride 0.3%. These include:
Side effects may be due to the administration technique. These include:
If a medicine has been added to the solution for infusion, this medicine may also cause side effects. These side effects will depend on the added medicine. You should read the list of possible symptoms in the package leaflet of the added medicine.
Reporting of side effects:
If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Viaflo Glucose 3.3% and Sodium Chloride 0.3% does not require special storage conditions.
Viaflo Glucose 3.3% and Sodium Chloride 0.3% should not be used after the expiry date stated on the bag after EXP. The expiry date is the last day of the month shown.
Do not receive Viaflo Glucose 3.3% and Sodium Chloride 0.3% if there are particles floating in the solution or if the packaging is damaged in any way.
Composition of Viaflo glucose 3.3% and sodium chloride 0.3%
The active ingredients are:
The other component is water for injectable preparations.
Appearance of the Product and Container Content
Viaflo glucose 3.3% and sodium chloride 0.3% is a clear and particle-free solution. It is presented in polyolefin/polyamide (Viaflo) plastic bags. Each bag is packaged in a sealed protective plastic overbag.
The bag sizes are
The bags are supplied in boxes, containing the following quantities:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Holder
Baxter S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Spain
Manufacturer: Baxter S.A. Av. René Branquart 80, Lessines Belgium |
Baxter Manufacturing Sp. z o.o.
42 B Wojciechowska Str., 20-0704 Lublin
Poland
Bieffe Medital S.A.
Ctra. Biescas-Senegüé s/n, 22666 Sabiñánigo
(Huesca), Spain
Date of the Last Revision of this Prospectus: October 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
……………………………………………………………………………………………………
This information is intended only for healthcare professionals
Handling and Preparation
Use only if the solution is clear, free of visible particles, and the container is not damaged. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the product's sterility.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air dragged from the primary container before the liquid contained in the secondary container is completely administered.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can lead to a gas embolism if the residual air in the container is not fully evacuated before administration.
The use of an intravenous administration set with a ventilation filter in the open position could cause a gas embolism. This type of intravenous administration set with the ventilation filter in the open position should not be used with flexible plastic containers.
The solution must be administered with sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air from entering the system.
Added medications can be introduced before or during infusion through the injection point. When adding medications, the tonicity should be checked before parenteral administration.
From a physico-chemical point of view, the solution containing added medications should be used immediately unless the chemical and physical stability in use has been established.
From a microbiological point of view, solutions containing added medications should be used immediately and should not be stored. If not used immediately, the storage conditions and period before use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless the reconstitution has been carried out in controlled and validated aseptic conditions.
Discard after a single use.
Discard partially used containers.
Do not reconnect partially used bags.
1- To Open
2- Preparation for Administration
Use sterile material for preparation and administration.
3- Techniques for Injecting Added Medication
Warning: Added medications may be incompatible. (See section 5 "Incompatibilities of Added Medications" below)
To Add Medication Before Administration
Precaution: Do not store bags with added medication. See section 4 "Expiry Date for Use".
To Add Medication During Administration
Before use, the physical and chemical stability of any added medication at the pH of the Viaflo glucose 3.3% and sodium chloride 0.3% solution in the Viaflo container must be established.
From a physico-chemical point of view, the solution containing added medications should be used immediately unless the chemical and physical stability in use has been established.
From a microbiological point of view, the diluted product should be used immediately. If not used immediately, the storage time and conditions before use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless the addition of medications has been carried out in controlled and validated aseptic conditions.
5- Incompatibilities of Added Medications
As with all parenteral solutions, the compatibility of added medications with the Viaflo bag solution must be verified before addition.
It is the responsibility of the physician to judge the incompatibility of the added medication to Viaflo glucose 3.3% and sodium chloride 0.3% by examining any change in color and/or precipitation, insoluble complexes, or the appearance of crystals. The prospectus of the medication to be added should be consulted.
Before adding a medication, verify that it is soluble and stable in water at the pH of Viaflo glucose 3.3% and sodium chloride 0.3% (pH 3.5-6.5).
When adding compatible medication to Viaflo glucose 3.3% and sodium chloride 0.3%, the solution should be administered immediately, unless the chemical and physical stability in use has been established.
As a guide, the following medications are incompatible with Viaflo glucose 3.3% and sodium chloride 0.3% (this is not an exhaustive list):
Since Viaflo glucose 3.3% and sodium chloride 0.3% contains glucose, it should not be administered with whole blood through the same infusion equipment, due to the possibility of hemolysis and agglutination.
Medications whose incompatibility is known should not be used.